Long-Term Prognostic Performance of Ki67 Rate in Early Stage, pT1-pT2, pN0, Invasive Breast Carcinoma

BACKGROUND: Molecular signatures may become of use in clinical practice to assess the prognosis of breast cancers. However, although international consensus conferences sustain the use of these new markers in the near future, concerns remain about their degree of discordance and cost-effectiveness i...

Descripción completa

Detalles Bibliográficos
Autores principales: Reyal, Fabien, Hajage, David, Savignoni, Alexia, Feron, Jean-Guillaume, Bollet, Marc Andrew, Kirova, Youlia, Fourquet, Alain, Pierga, Jean-Yves, Cottu, Paul, Dieras, Veronique, Fourchotte, Virginie, Laki, Fatima, Alran, Severine, Asselain, Bernard, Vincent-Salomon, Anne, Sigal-Zafrani, Brigitte, Sastre-Garau, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602517/
https://www.ncbi.nlm.nih.gov/pubmed/23526930
http://dx.doi.org/10.1371/journal.pone.0055901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602517/
https://www.ncbi.nlm.nih.gov/pubmed/23526930
http://dx.doi.org/10.1371/journal.pone.0055901

Ejemplares similares